Literature DB >> 21115155

Mouse models of adrenal tumorigenesis.

Constanze Hantel1, Felix Beuschlein.   

Abstract

Adrenocortical carcinomas (ACCs) are heterogeneous tumors with a poor prognosis. The rarity of this disorder causes a lack of treatment experience and material availability which is necessary to optimize existing treatments and to develop novel therapeutic strategies. Although surgery is still the treatment of choice, adjuvant therapies are urgently needed as the rate of recurrence for these tumors is high. In recent years molecular characterization of surgical tumor specimen has aided in the understanding of disease mechanisms and definition of therapeutic targets also in adrenocortical carcinoma. However, most of the functional properties of potential target molecules are still unpredictable from pure expression and sequence analysis. For functional studies of gene products, mouse models remain to be intensively utilized as an experimental system due to the similarity to humans with respect to genome organization, development and physiology. Here we give an overview on rodent models that have been described to either have adrenocortical tumors as part of their phenotype or have been utilized for therapeutic screens as adrenocortical tumor models. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21115155     DOI: 10.1016/j.beem.2010.10.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  4 in total

1.  Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells.

Authors:  Matthias Kroiss; Silviu Sbiera; Sabine Kendl; Max Kurlbaum; Martin Fassnacht
Journal:  Horm Cancer       Date:  2016-09-08       Impact factor: 3.869

2.  Endocrine-specific NIR fluorophores for adrenal gland targeting.

Authors:  Yoshitomo Ashitate; Andrew Levitz; Min Ho Park; Hoon Hyun; Vivek Venugopal; GwangLi Park; Georges El Fakhri; Maged Henary; Sylvain Gioux; John V Frangioni; Hak Soo Choi
Journal:  Chem Commun (Camb)       Date:  2016-08-11       Impact factor: 6.222

3.  Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agent.

Authors:  Emilia M Pinto; Christopher Morton; Carlos Rodriguez-Galindo; Lisa McGregor; Andrew M Davidoff; Kimberly Mercer; Larisa V Debelenko; Catherine Billups; Raul C Ribeiro; Gerard P Zambetti
Journal:  Clin Cancer Res       Date:  2013-02-13       Impact factor: 12.531

4.  Childhood adrenocortical tumor: A clinical and immunohistochemical study of 13 cases.

Authors:  Xiaohui Wu; Jun Xu; Jinhu Wang; Weizhong Gu; Chaochun Zou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.